The Pfizer Global Supply Kalamazoo manufacturing plant in Portage, MI on Friday, Dec. 11, 2020.  (AP Photo/Paul Sancya)
Dora Anne Mills, who is overseeing the vaccine rollout for Maine Health, which operates 10 hospitals, said they may get around 970 doses in this first round for the entire hospital system — covering a fraction of the 17,000 patient-facing employees the system would like to vaccinate as soon as possible.

“We are all facing the same dilemma. How do we stabilize the hospital systems at a time when we have so many doctors and nurses out because of covid exposure?” she said.

The hospital has been holding Zoom sessions to explain the vaccine to staff and convince them that it is safe to take. Mills said she is fine with her two adult children receiving the vaccine; she was not over the summer, but is now convinced of its safety and efficacy.

At Salt Lake City-based Intermountain Healthcare, a 23-hospital system that serves Utah, Idaho and Nevada, officials have asked those in the first group to receive the vaccine to sign up at the end of their week of shifts in case they have mild-to-moderate side effects in the days after they get the vaccine.

In Minnesota, which has reported one of the nation’s highest per capita rates of infection, state health officials have meticulously planned for months the rollout of the vaccine. The Minnesota Department of Health designated 25 main distribution hubs around the state which will deliver the vaccine to 118 smaller facilities, including in rural areas.

Gov. Tim Walz (D) said the state had embarked on several “dry runs” in recent weeks, trying to game out “every possible scenario” in the distribution process using a box sent by Pfizer containing “everything but the vaccine.”

But as obsessively as the state has planned, Walz acknowledged lingering concerns, including access to dry ice, which Walz said could pit the state and health care industry against Upper Midwest cheese and dairy producers which use dry ice to ship cheese curds.

In Florida, Gov. Ron DeSantis said this week that the state expects to get 180,000 doses of the Pfizer-BioNTech vaccine in the first release. Of those, 100,000 doses will go to five hospitals that can store the finicky vaccine.

The rest of the doses will go to nursing homes and long-term care facilities, and will be administered to both patients and staff, the governor said.

“It’s a very fluid situation, things are changing. But the plan is to get it on or before December 15,” said John Couris, president and CEO of Tampa General Hospital.

Couris noted some hesitancy among staff and will plan for that.

“If we say you must take the vaccine, if you don’t, what are we going to do? Terminate them?”

At the UF Health Jacksonville hospital the atrium will allow for social distancing, and also has space so those who get vaccinated can be monitored for 15 minutes after receiving the shot. The space is large enough to accommodate 500 to 1,000 people a day, said Leon Haley Jr., CEO of UF Health Jacksonville and Dean of the University of Florida’s College of Medicine in Jacksonville.

Haley said he doesn’t know how many doses to expect. He will be videotaped getting one of the first doses of the vaccine as a PSA for other staff.

“We definitely have some people that are very enthusiastic, they can’t wait to be in first,” Haley said. “But we have a couple of people that are still on the bubble.

Riverside Health System, based in Newport News, Va., will receive 975 doses for five hospitals. It expects to start vaccinating personnel at highest risk for covid exposure Wednesday, including doctors, nurses and housekeeping staff, said Cindy Williams, Riverside’s chief pharmacy officer.

Like many hospital systems, Riverside’s loading dock only operates Monday through Friday. If the vaccine is shipped Sunday, the hospital would receive it Monday. Ancillary supply kits of needles and syringes are being sent separately.

“There are so many moving pieces,” Williams said.

The system is used to administering flu shots, but must change its clinic layout for the coronavirus vaccine to allow for social distancing and recipients to be monitored for 30 minutes post-jab.

The health system had previously surveyed employees before news about the efficacy of the two vaccines and found about a third of respondents were willing to get a shot. But a more recent survey this week found that about 60 percent were interested in getting the vaccine, Williams said.

At the University of Pittsburgh Medical Center, a team of in-house experts is reviewing the vaccine data, to double-check the FDA’s decision before vaccinations are given to health care staff.

“We have convened our group of experts to independently review the data on these vaccines,” Graham Snyder, medical director for infection prevention and hospital epidemiology, said at a briefing this week. “I want our experts … to tell us that the vaccines are safe and effective to use in our communities.”

Sauer of Hopkins said she is concerned about the emotional burdens being placed on already exhausted health care workers as they are turned into role models. They will be asked about their experience and whether they did or did not take the vaccine, she said, possibly for personal health reasons.

“We are asking them to take a brand new vaccine and then in addition to be advocates for patients, friends, family members,” Sauer said.

“That is a lot to ask during a pandemic.”

Andrew Becker in Salt Lake City, Lori Rozsa in West Palm Beach, Fla., Kayla Ruble in Detroit and Cid Standifer in Cleveland contributed reporting.